We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Alpha Lipoic Acid vs Propolis: Alpha Lipoic Acid has the stronger overall evidence (7 vs 5.5/10); they're alternatives for inflammation-related symptoms — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Alpha Lipoic Acid wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
8 of 10 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
4 of 4 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Alpha Lipoic Acid and Propolis have evidence — compare verdict strength side-by-side.
300-600mg
On empty stomach for best absorption, 30-60 minutes before meals
R-Alpha Lipoic Acid (R-ALA) — the natural form
300-600 mg daily (standardized extract). The cited trials used 400 to 600 mg a day. Label products go up to 1,000 mg, above that dose.
With food, Divided doses for higher amounts, Throat spray can be used as needed
Standardized extract (capsules or tincture)
4-12 weeks
4-8 weeks
2-4 weeks
1-2 weeks
2-4 weeks
1-2 weeks
Acute
Effects of Oral Alpha-Lipoic Acid Treatment on Diabetic Polyneuropathy: A Meta-Analysis and Systematic Review
Nutrients (2023) · Meta analysis · n=1242
ALA treatment produced favorable results for TSS (a dose-related trend was observed), NDS, and the global satisfaction score.
Effects of selected dietary supplements on migraine prophylaxis: A systematic review and dose-response meta-analysis of randomized controlled trials
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2025) · Meta analysis
Twenty-two trials were included in the systematic review and meta-analysis.
The Effect of Dietary Supplements on Male Infertility in Terms of Pregnancy, Live Birth, and Sperm Parameters: A Systematic Review and Meta-Analysis
Nutrients (2025) · Meta analysis
Systematic review and meta-analysis of 50 placebo-controlled trials of dietary supplements lasting at least 12 weeks in infertile men.
Dosage exploration of the effects of honey and its derivatives on cardiometabolic outcomes: an overview of systematic reviews and GRADE-assessed updated meta-analysis
Nutrition & diabetes (2025) · Meta analysis · n=3544
Umbrella review and updated meta-analysis of 69 randomised trials with 3,544 participants across honey, royal jelly and propolis together. The abstract does not say how many trials or participants were propolis.
The impact of propolis supplementation on inflammatory biomarkers: A meta-analysis and systematic review of randomized controlled clinical trials
Prostaglandins & other lipid mediators (2024) · Meta analysis · n=1139
The propolis supplementation significantly reduced IL-6 (WMD = -2.48; 95 % CI: -4.62, -0.34; P = 0.023) and TNF-α (WMD = -0.86; 95 % CI: -1.45, -0.26; P = 0.005) compared with control groups.
Potential Effects of Bioactive Compounds of Plant-Based Foods and Medicinal Plants in Chronic Kidney Disease and Dialysis: A Systematic Review
Nutrients (2024) · Systematic review
Systematic review of randomised trials of plant compounds and medicinal plants in chronic kidney disease and dialysis. Propolis was 3 of the trials, beside curcumin (8), sulforaphane, genistein, allicin, beetroot, green tea, rhubarb, astragalus and Tripterygium.
The points come from the SYDNEY 2 trial (PMID 17065669), which gave 181 people with diabetic polyneuropathy 600, 1,200 or 1,800 mg once daily or placebo for 5 weeks. All three doses beat placebo on the Total Symptom Score, with about the same size of effect: responder rates (a 50% or greater fall) were 62%, 50% and 56% against 26% on placebo, and effectiveness here is the responder rate above placebo. Nausea, vomiting and vertigo rose with dose, and the authors judged 600 mg once daily the best balance of benefit and risk. Doses below 600 mg were not tested. A 6-month trial of 1,200 mg a day in 200 patients (PMID 32370731) found benefit with mild nausea in 6 patients and no withdrawals, which is the basis for the 1,200 mg ceiling. A meta-analysis of 10 trials reported a dose-related trend in symptom scores (PMID 37630823), which the one head-to-head dose trial did not show.
AI-estimated from published studies. Interpret as directional guidance.
Alpha Lipoic Acid has a higher evidence score (7/10 vs 5.5/10) and wins in 2 of 3 categories.
For inflammation-related symptoms, Alpha Lipoic Acid has a higher relevance score (80 vs 70).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.